Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Inherited Metabolic Disorders (IMD): early-phase trial registry
2 of 2 indexed Inherited Metabolic Disorders (IMD) trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · 2 currently recruiting · #7,188 of 28,707 conditions by registered trial count
Inherited Metabolic Disorders (IMD): 2 US clinical trials tracked, 2 recruiting.
Inherited Metabolic Disorders (IMD) is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Paul Szabolcs, running 2 of these trials.
Enrollment posture brief
Registry condition inherited-metabolic-disorders-imd
OPEN 2 | RECR 100% | LATE 0 | EARLY 1 | RANK #7188 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Inherited Metabolic Disorders (IMD) lists 2 open slots (100% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Inherited Metabolic Disorders (IMD) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Inherited Metabolic Disorders (IMD) is recruiting above its size-band peers.
2 of 2 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
2 total, page 1 of 1
Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Paul Szabolcs
NCT01962415
Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Paul Szabolcs
NCT04528355
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Inherited Metabolic Disorders (IMD) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Inherited Metabolic Disorders (IMD) trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Inherited Metabolic Disorders (IMD) page
2 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Inherited Metabolic Disorders (IMD) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Paul Szabolcs sponsors the most Inherited Metabolic Disorders (IMD) trials on record, review their full trial history before evaluating a specific study. See Paul Szabolcs's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Inherited Metabolic Disorders (IMD) condition card totals 2 registered trials; most-linked intervention data collection; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.